Cell Therapies for Atrophic AMD

Related

• 

  Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

  Peter A. Campochiaro, MD

  Updates from the Field

  2020

• 

  The Updated AREDS Simplified Severity Scale for Age-Related Macular Degeneration, Incorporating Reticular Pseudodrusen

  Tiarnan D Keenan, BM BCh, PhD

  Updates from the Field

  2024

• 

  Multiwavelength Photobiomodulation Significantly Reduces Risk for Vision Loss and Onset of Geographic Atrophy in Dry Age-Related Macular Degeneration

  Eleonora Lad, MD, PhD

  Updates from the Field

  2024